Day 2: Substance Abuse – Lessons learned and where are we going?
Click on presenter's name for link to video or publications.
Note: Some presentations contained unpublished data; therefore, several speakers have provided published manuscripts related to their talks.
Day 2 end of day Panel Discussion
 |
Rick Bevins, PhD University of Nebraska-Lincoln Bio-behavioral factors affecting the abuse liability of nicotine |
 |
Olivier George, PhD The Scripps Research Institute Identification of novel targets for cocaine and opioid use disorders using heterogeneous stock rats |
 |
Klaus Miczek, PhD |
 |
Subhash C. Pandey, PhD
University of Illinois at Chicago Emerging Role of Epigenetic Regulation in Alcohol Use Disorders
|
 |
Tariq Rana, PhD University of California-San Diego Health Sciences Epigenetic and Epitranscriptomic Regulation of HIV infection |
 |
Sabita Roy, PhD University of Miami Microbial dysbiosis observed in Morphine tolerant animals is attenuated in germ free mice and reversed in probiotic treated WT mice |
 |
Pietro Sanna, MD The Scripps Research Institute Stimulant abuse and HIV infection - animal models |
 |
Mohan Sopori, PhD Lovelace Respiratory Research Institute Interaction between HIV and cigarette smoke in the development of chronic lung diseases |
 |
Minglei Guo, PhD University of Nebraska Medical Center Role of Microglial activation in cocaine addiction (short talk) |
 |
Guoku Hu, PhD University of Nebraska Medical Center Extracellular vesicle-induced-lincRNA-Cox2 impairs microglial function in opioid users (short talk) |
|
Visit Day 1 NeuroHIV – from bed to bench side for speaker presentations.
|
|